Ibio Inc (IBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IBIO | AMGN | GILD | VRTX | REGN |
| Company | Ibio Inc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.7960 | 272.14 | 67.09 | 404.00 | 905.66 |
| High | 1.9300 | 274.48 | 67.68 | 406.86 | 912.74 |
| Low | 1.7472 | 271.05 | 67.06 | 403.47 | 903.83 |
| Last | 1.9100 | 273.56 | 67.24 | 405.36 | 907.47 |
| Change | +0.1300 | +1.65 | +0.29 | +5.44 | +7.31 |
| % Change | +7.30% | +0.61% | +0.43% | +1.36% | +0.81% |
| Volume | 130,405 | 1,514,451 | 2,885,913 | 517,912 | 183,039 |
| 20-Day Average Volume | 11,869,025 | 2,165,095 | 6,213,188 | 948,569 | 434,187 |
| Previous Close | 1.7800 | 271.91 | 66.95 | 399.92 | 900.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.2865 | 272.00 | 69.35 | 404.22 | 929.24 |
| 20-Day Raw Stochastic | 21.29% | 47.34% | 18.00% | 48.88% | 21.83% |
| 20-Day Relative Strength | 51.22% | 49.02% | 34.52% | 48.69% | 40.55% |
| Weighted Alpha | -86.88 | +11.64 | -20.36 | +18.13 | +14.34 |
| Today's Opinion | 8% Sell | 40% Sell | 100% Sell | 24% Buy | 24% Buy |
| Previous Opinion | 8% Sell | 40% Sell | 100% Sell | 8% Buy | 24% Buy |
| Last Month's Opinion | 88% Sell | 8% Buy | 88% Sell | 40% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.05% since 04/16/24 | +3.10% since 04/16/24 | +0.04% since 04/16/24 | +2.97% since 04/16/24 | +1.69% since 04/16/24 |
| Low | 1.6700 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 891.46 on 04/19/24 |
| High | 1.9700 on 04/17/24 | 274.48 on 04/23/24 | 67.68 on 04/23/24 | 406.86 on 04/23/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | +75.23% since 03/22/24 | -0.83% since 03/22/24 | -7.26% since 03/22/24 | -2.35% since 03/22/24 | -5.99% since 03/22/24 |
| Low | 1.0798 on 03/26/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 |
| High | 4.9800 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | +76.85% since 01/23/24 | -11.63% since 01/23/24 | -15.28% since 01/23/24 | -7.69% since 01/23/24 | -4.75% since 01/23/24 |
| Low | 1.0500 on 03/20/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 |
| High | 4.9800 on 03/28/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -68.30% since 10/23/23 | +0.30% since 10/23/23 | -13.18% since 10/23/23 | +10.40% since 10/23/23 | +14.30% since 10/23/23 |
| Low | 1.0214 on 01/18/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 | 769.19 on 10/27/23 |
| High | 6.4680 on 11/06/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,202 | 145,845,984 | 83,357,904 | 103,362,928 | 98,803,360 |
| Shares Outstanding, K | 3,484 | 536,376 | 1,245,077 | 258,459 | 109,762 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | -65,010,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 50,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 3,434,300,000 |
| Last Quarter Net Income | -5,750,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 1,159,600,000 |
| 60-Month Beta | -3.53 | 0.58 | 0.19 | 0.35 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.42 on 02/09/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/10/24 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.42 | 9.93 | 29.34 | 23.86 |